MPLT – maplight therapeutics, inc. (US:NASDAQ)
Stock Stats
News
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 [Yahoo! Finance]
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Wall Str
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
Form 8-K MapLight Therapeutics, For: Jan 09
Form 10-Q MapLight Therapeutics, For: Sep 30
Form 8-K MapLight Therapeutics, For: Dec 04
Form SCHEDULE 13D MapLight Therapeutics, Filed by: Catalyst4, Inc.
Form 3/A MapLight Therapeutics, For: Oct 25 Filed by: Pavlov George
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.